Niagen Bioscience Sponsors Inaugural NAD for Health Conference in Copenhagen

Niagen Bioscience Inc. (NASDAQ: NAGE), a global authority on NAD+ science focused on healthy aging, will serve as the premiere sponsor of the inaugural “NAD for Health: Opportunities & Challenges” scientific conference. The event is set to take place March 23-25, 2026, at the Royal Danish Academy of Sciences and Letters in central Copenhagen. Hosted by the University of Copenhagen, the three-day forum will bring together leading global experts to discuss the latest advancements in NAD+ research, including its role in metabolism, mitochondrial function, DNA repair, and neurodegenerative diseases. For more details about the conference, visit the official event website: https://eventsignup.ku.dk/nadforhealth. Additional information about Niagen Bioscience can be found at www.niagenbioscience.com. Interested attendees must register in advance, with space limited and attendance subject to confirmation. Contact Cathleen Brahms, Events Manager at Niagen Bioscience, at cathleen.brahms@niagenbio.com by Sunday, February 15, 2026, to inquire about registration.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Niagen Bioscience Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260209960394) on February 09, 2026, and is solely responsible for the information contained therein.